Cargando…
Individualized intensified antiplatelet therapy based on platelet reactivity testing reduces the incidence of cardiovascular events in patients undergoing percutaneous coronary intervention
Autores principales: | Spartalis, Michael, Tzatzaki, Eleni, Nikiteas, Nikolaos I., Spartalis, Eleftherios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kare Publishing
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731292/ https://www.ncbi.nlm.nih.gov/pubmed/29145223 http://dx.doi.org/10.14744/AnatolJCardiol.2017.8009 |
Ejemplares similares
-
Uninterrupted dabigatran is safer than warfarin in patients undergoing
ablation for atrial fibrillation
por: Spartalis, Michael, et al.
Publicado: (2017) -
Parvovirus B19 Myocarditis of Fulminant Evolution
por: Spartalis, Michael, et al.
Publicado: (2017) -
Pathophysiology and Current Evidence for Detection of Dyssynchrony
por: Spartalis, Michael, et al.
Publicado: (2017) -
The Role of Echocardiography in the Optimization of Cardiac Resynchronization Therapy: Current Evidence and Future Perspectives
por: Spartalis, Michael, et al.
Publicado: (2017) -
Ischemic Stroke in a Patient With Quadricuspid Aortic Valve and Patent Foramen Ovale
por: Spartalis, Michael, et al.
Publicado: (2017)